The panel portion of the event will run until 4 PM, and then there will be a networking reception from 4 - 5 PM. Food and drinks will be provided.
Courtney Burrows, PhD, is currently a second year student the University of Chicago Booth School of Business. This summer Courtney interned with the commercial marketing launch team for AbbVie's VENCLEXTA, a Bcl-2 inhibitor used to treat chronic lymphocytic leukemia. She will be returning to AbbVie next year as part of the Commercial Leadership Program. Prior to Booth, Courtney got her Ph.D. from the University of Chicago in Human Genetics in Dr. Yoav Gilad's lab. While getting her Ph.D. she was involved in the launch of myCHOICE, the Innovation Fund Associate Program, and the UCBA. Courtney earned her BS and BA in Biology and Anthropology from the University of Florida.
Jacob Degner, PhD, is a Senior Scientist at the global pharmaceutical company, AbbVie. He works within the Pharmacogenetics and Pharmacogenomics division, where he applies his academic training in bioinformatics, statistics, and genetics to understanding the genetic basis of disease and inter-individual variation in drug response across a wide range of therapeutic areas. Jacob finished his Ph.D. in 2012 in the Committee on Genetics, Genomics, and Systems Biology at the University of Chicago under Dr. Jonathan Pritchard. His research focused on identifying regulatory regions in the human genome and on understanding the molecular mechanisms that link DNA-level variation to heritable variation in gene expression. He did postdoctoral work at the U of C and at EMBL as well.
Ryan Duggan is a Senior scientist at AbbVie, where his specialties include: Flow Cytometry, Image Cytometry, Biomedical Research, Technology, Data Analysis, Core Facility Management, and Core Facility Marketing. Before joining Abbvie, he got his BA in Psychology at the University of Chicago in 2002, then worked as a Research Technologist, and as the Flow Cytometry Technical Director at the UChicago Flow Cytometry Core.
Brett Englemann, PhD, is a Senior Biology Data Scientist with AbbVie where he supports the analysis and visualization of genomic and proteomic data from early stage applied research to AbbVie clinical trials. His primary interests are phosphorylation mediated signaling and empowering disease area experts with data driven insights. Prior to joining AbbVie, Brett was a postdoctoral fellow at the University of Chicago where he investigated the statistical relationships between inter-individual genetic variation and phosphoproteomic signatures. Brett received his Ph.D. in 2013 from the Department of Biochemistry and Molecular Biology at the University of Chicago.
A. Jason Grundstad possesses bachelor degrees in Biology and Computer Science, with 14 years professional experience as a staff computational scientist in a genetic research setting. Before starting at AbbVie in Feb 2016, Jason was employed as a Bioinformatics Programmer and Applications Developer at the University of Iowa’s Coordinated Laboratory for Computational Genomics, and then as Senior Bioinformatics Programmer at the University of Chicago’s Institute for Genomics and Systems Biology (2010-2016). His most recent work at the University of Chicago largely included the support IGSB’s High-throughput Genome Analysis Center (HGAC), where he gained a broad exposure to NGS data generation, management, and analysis. In his current position as Principal Bioinformatics Analyst in the Computational Genomics department of AbbVie’s newly formed Genomics Research Center, his work is focused on building their NGS data management infrastructure, as well as implementing and automating analysis pipelines.
Date and Time
924 East 57th Street
Chicago, IL 60637